UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 317

Sortiert nach

Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem progenitor cells

Leukemia, 2011-06, Vol.25 (6), p.985-994

2011

Volltextzugriff (PDF)

The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem progenitor cells

Leukemia, 2011-07, Vol.25 (7), p.1159-1167

2011

Volltextzugriff (PDF)

Nilotinib concentration in cell lines and primary CD34 chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters

Leukemia, 2009-11, Vol.23 (11), p.1999-2006

2009

Volltextzugriff (PDF)

Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors

Leukemia, 2008-04, Vol.22 (4), p.748-755

2008

Volltextzugriff (PDF)

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease

Leukemia, 2005-03, Vol.19 (3), p.435-441

2005

Volltextzugriff (PDF)

Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1

Leukemia, 2012-07, Vol.26 (7), p.1555-1563

2012

Volltextzugriff (PDF)

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia

Leukemia, 2002-04, Vol.16 (4), p.549-558

2002

Volltextzugriff (PDF)

A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (4), p.389-395

2005

Volltextzugriff (PDF)

Targeting survival pathways in chronic myeloid leukaemia stem cells

British journal of pharmacology, 2013-08, Vol.169 (8), p.1693-1707

2013

Volltextzugriff (PDF)

Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro

Leukemia, 2005-07, Vol.19 (7), p.1184-1191

2005

Volltextzugriff (PDF)

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Leukemia, 2020-07, Vol.34 (7), p.1775-1786

2020

Volltextzugriff (PDF)

No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy‐related infections

Clinical and experimental immunology, 2003-11, Vol.134 (2), p.279-284

2003

Volltextzugriff (PDF)

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

Blood, 2000-03, Vol.95 (6), p.1883-1890

2000

Volltextzugriff (PDF)

Dysregulated expression of the major telomerase components in leukaemic stem cells

Leukemia, 2005-03, Vol.19 (3), p.381-389

2005

Volltextzugriff (PDF)

Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity

Journal of leukocyte biology, 2006-10, Vol.80 (4), p.862-869

2006

Volltextzugriff (PDF)

Mtss1 is a critical epigenetically regulated tumor suppressor in CML

Leukemia, 2016-04, Vol.30 (4), p.823-832

2016

Volltextzugriff (PDF)

Characterization of cancer stem cells in chronic myeloid leukaemia

Biochemical Society transactions, 2007-11, Vol.35 (Pt 5), p.1347

2007

Volltextzugriff (PDF)

Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia

Cancer Immunology, Immunotherapy, 2005-04, Vol.54 (4), p.297-306

2005

Volltextzugriff (PDF)

Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency

Bone marrow transplantation (Basingstoke), 2005-01, Vol.35 (2), p.179-181

2005

Volltextzugriff (PDF)

Is there a cloud in the silver lining for imatinib?

British journal of cancer, 2003-04, Vol.88 (7), p.983-987

2003

Volltextzugriff (PDF)

Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones

Leukemia, 2003-03, Vol.17 (3), p.634-635

2003

Volltextzugriff (PDF)

CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1839-1847

1996

Volltextzugriff (PDF)

CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens

Bone marrow transplantation (Basingstoke), 1997-06, Vol.19 (11), p.1095-1101

1997

Volltextzugriff (PDF)

A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (sti 571, glivec®)

British journal of haematology, 2003-03, Vol.120 (5), p.911-913

2003

Volltextzugriff (PDF)

Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the clinical trials committee of the British Society of Blood & Marrow Transplantation (BSBMT)

Bone marrow transplantation (Basingstoke), 2005-12, Vol.36 (12), p.1065-1069

2005

Volltextzugriff (PDF)

1 – 25 von 317

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Englisch
(316)
Japanisch
(45)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(203)
Life Sciences & Biomedicine
(198)
Humans
(182)
Hematology
(113)
Biological And Medical Sciences
(84)
Medical Sciences
(77)
Animals
(71)
Oncology
(71)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Pathology
(65)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(63)
Chronic Myeloid Leukemia
(56)
Imatinib Mesylate
(56)
Benzamides
(50)
Male
(50)
Hematologic And Hematopoietic Diseases
(49)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(47)
Female
(45)
Leukemia
(45)
Stem Cells
(42)
Mice
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem progenitor cells

The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem progenitor cells

Nilotinib concentration in cell lines and primary CD34 chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters

Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease

Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia

A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients

Targeting survival pathways in chronic myeloid leukaemia stem cells

Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy‐related infections

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

Dysregulated expression of the major telomerase components in leukaemic stem cells

Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity

Mtss1 is a critical epigenetically regulated tumor suppressor in CML

Characterization of cancer stem cells in chronic myeloid leukaemia

Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia

Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency

Is there a cloud in the silver lining for imatinib?

Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones

CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity

CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens

A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (sti 571, glivec®)

Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the clinical trials committee of the British Society of Blood & Marrow Transplantation (BSBMT)

Suchergebnisse filtern